Nuclear medicine and radiopharmaceutical manufacturing market is estimated more than USD 6 billion

The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharmaceuticals

Roots Analysis is pleased to announce the publication of its recent study, titled, “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030”

The report provides a detailed study on the current market landscape and future potential of the companies having the capabilities to manufacture radiopharmaceuticals. In addition, the study features an in-depth analysis, highlighting the capabilities of a diverse set of industry stakeholders. Amongst other elements, the report features the following:

A detailed assessment of the current market landscape with respect to the players (industry and non-industry) involved in manufacturing radiopharmaceuticals.An insightful four-dimensional comparison of the radiopharmaceutical manufacturers.Tabulated profiles of key industry players based in North America, Europe and Asia-Pacific (shortlisted based on the company size of the players).An analysis of recent partnerships and collaborations inked in this domain since 2017.A detailed discussion on the supply chain model of medical isotope Mo-99 (Tc-99m).A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Target Therapeutic Area

Cardiology

Neurology

Oncology

Thyroid

Others

Application Area

Diagnostic

Therapeutic

Type of Diagnostic Radiopharmaceuticals

PET

SPECT

Type of Therapeutic Radiopharmaceuticals

Alpha Emitters

Beta Emitters

Others

Purpose of Production

In-House

Outsourcing

Key Geographical Region

North America

Europe

Asia-Pacific and the Rest of the World

Transcripts of interviews held with the following senior level representatives of stakeholder companies

J James Davis, Vice President Quality / R&D, Shertech LaboratoriesAndreas Fotopoulos, Professor of Nuclear Medicine, University of Ioannina Medical SchoolJan Pruim, Professor of Medical Imaging / Nuclear Medicine Physician, University Medical Center of GroningenMichael van Dam, Professor, Crump Institute for Molecular Imaging, Molecular & Medical PharmacologyAnonymous, ITM Isotopen Technologien München

Key companies covered in the report

Advanced Accelerator ApplicationsBelgian Nuclear Research Center (SCK•CEN)Cardinal HealthChina Isotope & Radiation CorporationCurium PharmaDuChemBioEckert & ZieglerEczacibasi-MonrolGE HealthcareJubilant DraxImageLantheus Medical ImagingNihon Medi-PhysicsNordionPETNET SolutionsSinoTau PharmaceuticalsSOFIE

For more information please click on the following link:

https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html

Other Recent Offerings

High Energy Chemistry / Hazardous Chemistry-based API Manufacturing Services Market: Focus on High Temperature, Low Temperature / Cryogenic, High Pressure and Low Pressure Chemistries, 2020-2030Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]